For research use only. Not for therapeutic Use.
Bimagrumab（Cat No.:I042237）is a monoclonal antibody that targets and inhibits the activin type II receptor, which regulates muscle growth and development. By blocking this receptor, Bimagrumab promotes muscle growth and regeneration, making it a promising treatment for conditions associated with muscle loss or weakness, such as sarcopenia, muscular dystrophy, and cachexia. Clinical trials have shown that Bimagrumab can increase muscle mass and improve strength in patients with certain muscle-wasting conditions. Research continues to assess its safety, efficacy, and potential as a therapeutic option for enhancing muscle function in various diseases.
| Catalog Number | I042237 |
| CAS Number | 1356922-05-8 |
| Purity | ≥95% |
